Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Scalable production of influenza virus in HEK-293 cells for efficient vaccine manufacturing

27 Mar 2010

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Viral gastroenteritis research and epidemiology
Share to Viral Infectious Diseases and Gene Expression in Insects
Share to Virus-based gene therapy research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 20347632
DOI: 10.1016/j.vaccine.2010.03.029

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Scalable production of influenza virus in HEK-293 cells for efficient vaccine manufacturingPMID 20347632Read ↗

Production of virus-like particles for vaccinesSemantic proximity Read ↗

Critical assessment of influenza VLP production in Sf9 and HEK293 expression systemsSemantic proximity Read ↗

Influenza vaccines: recent advances in production technologiesSemantic proximity Read ↗

From single‐cell cloning to high‐yield influenza virus production – implementing advanced technologies in vaccine process developmentSemantic proximity Read ↗

Platforms, advances, and technical challenges in virus-like particles-based vaccinesSemantic proximity Read ↗

Innovations in cell culture-based influenza vaccine manufacturing – from static cultures to high cell density cultivationsSemantic proximity Read ↗

Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical developmentSemantic proximity Read ↗

Challenges for the production of virus-like particles in insect cells: The case of rotavirus-like particlesSemantic proximity Read ↗

Advances and challenges in enveloped virus-like particle (VLP)-based vaccinesSemantic proximity Read ↗

Enterovirus 71 virus-like particle vaccine: Improved production conditions for enhanced yieldSemantic proximity Read ↗

A scalable downstream process for the purification of the cell culture-derived Orf virus for human or veterinary applicationsSemantic proximity Read ↗

Rapid and Scalable Production of Functional SARS-CoV-2 Virus-like Particles (VLPs) by a Stable HEK293 Cell PoolSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.